{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-277420","form_type":"8-K","ticker":"DNA","cik":"0001830214","company_name":"Ginkgo Bioworks Holdings, Inc.","filed_at":"2021-09-20T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.947792+00:00","generated_at":"2026-06-29T02:45:03.395653+00:00","sec_items":["1.01","2.01","9.01","3.02","4.01","3.03","8.01","5.01","5.02","5.03","5.06"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Ginkgo Bioworks completes $15.8B SPAC merger; begins NYSE trading under DNA","bullets":["Transaction valued at ~$15.8B; Old Ginkgo equity holders received ~49.08 New Ginkgo shares per old share.","PIPE investment of $760M (76M shares at $10.00) raised concurrently with closing.","Earn-out shares up to 188.7M shares vest based on stock price targets ($12.50/$15.00/$17.50/$20.00) over 5 years.","Post-closing shares outstanding: ~1.75B Class A and B common (excluding earn-out and warrants); total ~2.01B.","Class A common and warrants began trading on NYSE Sept 17, 2021 under symbols DNA and DNA.WS."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-277420","json":"https://secwatch.observer/filing/0001193125-21-277420.json","markdown":"https://secwatch.observer/filing/0001193125-21-277420.md","text":"https://secwatch.observer/filing/0001193125-21-277420.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/d186750d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T02:45:03.395653+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"004f8fbed8","claim":"Reshma Shetty was appointed as President and Chief Operating Officer at Ginkgo Bioworks Holdings, Inc..","evidence_excerpt":"Ms. Shetty was appointed as President and Chief Operating Officer;","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Operating Officer"}],"fact_type":"executive_change"},{"claim_id":"29acf1244c","claim":"Jason Kelly was appointed as Director at Ginkgo Bioworks Holdings, Inc..","evidence_excerpt":"Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"37cf709141","claim":"Dennis A. Miller departed as Director at Ginkgo Bioworks Holdings, Inc..","evidence_excerpt":"Scott M. Delman, Joshua Kazam, Isaac Lee, Timothy Leiweke, Dennis A. Miller, Laurence E. Paul, and Harry E. Sloan ceased serving on SRNG’s board of directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"3e8f54f425","claim":"Arie Belldegrun was appointed as Director at Ginkgo Bioworks Holdings, Inc..","evidence_excerpt":"Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"4563d0b399","claim":"Mark Dmytruk was appointed as Chief Financial Officer at Ginkgo Bioworks Holdings, Inc..","evidence_excerpt":"Mark Dmytruk was appointed as Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"7f392e7afb","claim":"Christian Henry was appointed as Director at Ginkgo Bioworks Holdings, Inc..","evidence_excerpt":"Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"8099de3083","claim":"Laurence E. Paul departed as Director at Ginkgo Bioworks Holdings, Inc..","evidence_excerpt":"Scott M. Delman, Joshua Kazam, Isaac Lee, Timothy Leiweke, Dennis A. Miller, Laurence E. Paul, and Harry E. Sloan ceased serving on SRNG’s board of directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"88ea878cc6","claim":"Reshma Kewalramani was appointed as Director at Ginkgo Bioworks Holdings, Inc..","evidence_excerpt":"Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"9424a85104","claim":"Jason Kelly was appointed as Chief Executive Officer at Ginkgo Bioworks Holdings, Inc..","evidence_excerpt":"Mr. Kelly was appointed as the Company’s Chief Executive Officer;","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"974b98999b","claim":"Shyam Sankar was appointed as Director at Ginkgo Bioworks Holdings, Inc..","evidence_excerpt":"Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"a6ae678cbc","claim":"Harry E. Sloan departed as Director at Ginkgo Bioworks Holdings, Inc..","evidence_excerpt":"Scott M. Delman, Joshua Kazam, Isaac Lee, Timothy Leiweke, Dennis A. Miller, Laurence E. Paul, and Harry E. Sloan ceased serving on SRNG’s board of directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b9739469f5","claim":"Harry E. Sloan was appointed as Director at Ginkgo Bioworks Holdings, Inc..","evidence_excerpt":"Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"bae095ce86","claim":"Joshua Kazam departed as Director at Ginkgo Bioworks Holdings, Inc..","evidence_excerpt":"Scott M. Delman, Joshua Kazam, Isaac Lee, Timothy Leiweke, Dennis A. Miller, Laurence E. Paul, and Harry E. Sloan ceased serving on SRNG’s board of directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"bb9dbff4f1","claim":"Scott M. Delman departed as Director at Ginkgo Bioworks Holdings, Inc..","evidence_excerpt":"Scott M. Delman, Joshua Kazam, Isaac Lee, Timothy Leiweke, Dennis A. Miller, Laurence E. Paul, and Harry E. Sloan ceased serving on SRNG’s board of directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"d55455085a","claim":"Reshma Shetty was appointed as Director at Ginkgo Bioworks Holdings, Inc..","evidence_excerpt":"Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"df0fdae83c","claim":"Isaac Lee departed as Director at Ginkgo Bioworks Holdings, Inc..","evidence_excerpt":"Scott M. Delman, Joshua Kazam, Isaac Lee, Timothy Leiweke, Dennis A. Miller, Laurence E. Paul, and Harry E. Sloan ceased serving on SRNG’s board of directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"e17d3a60ed","claim":"Timothy Leiweke departed as Director at Ginkgo Bioworks Holdings, Inc..","evidence_excerpt":"Scott M. Delman, Joshua Kazam, Isaac Lee, Timothy Leiweke, Dennis A. Miller, Laurence E. Paul, and Harry E. Sloan ceased serving on SRNG’s board of directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"ffc0928e6f","claim":"Marijn Dekkers was appointed as Director at Ginkgo Bioworks Holdings, Inc..","evidence_excerpt":"Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}